These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 17558653)
21. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis. de Brito Rocha S; Baldo DC; Andrade LEC Adv Rheumatol; 2019 Jan; 59(1):2. PubMed ID: 30657101 [TBL] [Abstract][Full Text] [Related]
22. [Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis]. Orbach H; Shoenfeld Y Harefuah; 2003 Mar; 142(3):182-5, 239. PubMed ID: 12696470 [TBL] [Abstract][Full Text] [Related]
23. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. van Venrooij WJ; Zendman AJ; Pruijn GJ Autoimmun Rev; 2006 Nov; 6(1):37-41. PubMed ID: 17110315 [TBL] [Abstract][Full Text] [Related]
24. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Wegner N; Lundberg K; Kinloch A; Fisher B; Malmström V; Feldmann M; Venables PJ Immunol Rev; 2010 Jan; 233(1):34-54. PubMed ID: 20192991 [TBL] [Abstract][Full Text] [Related]
25. Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease. Fisher BA; Bang SY; Chowdhury M; Lee HS; Kim JH; Charles P; Venables P; Bae SC Ann Rheum Dis; 2014 Apr; 73(4):741-7. PubMed ID: 23505239 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440 [TBL] [Abstract][Full Text] [Related]
27. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078 [TBL] [Abstract][Full Text] [Related]
28. [The pathogenic role of ACPA in rheumatoid arthritis]. Umeda N; Matsumoto I; Sumida T Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):391-395. PubMed ID: 29367523 [TBL] [Abstract][Full Text] [Related]
29. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519 [TBL] [Abstract][Full Text] [Related]
30. [The vicious circle that leads to rheumatoid arthritis; experimental evidence of the steps involved in this circle]. van Venrooij WJ; Pruijn GJ Ned Tijdschr Geneeskd; 2009; 153():B232. PubMed ID: 19785789 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis. Maraina CH; Nurdayana AK; Rusni D; Azwany Y Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468 [TBL] [Abstract][Full Text] [Related]
32. [Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis]. Erre GL; Tocco A; Faedda R; Cossu A; Carcassi A Reumatismo; 2004; 56(2):118-23. PubMed ID: 15309221 [TBL] [Abstract][Full Text] [Related]
33. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis. Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921 [TBL] [Abstract][Full Text] [Related]
34. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis. Farid SSh; Azizi G; Mirshafiey A Int J Rheum Dis; 2013 Aug; 16(4):379-86. PubMed ID: 23992255 [TBL] [Abstract][Full Text] [Related]
35. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ioan-Facsinay A; el-Bannoudi H; Scherer HU; van der Woude D; Ménard HA; Lora M; Trouw LA; Huizinga TW; Toes RE Ann Rheum Dis; 2011 Jan; 70(1):188-93. PubMed ID: 20736390 [TBL] [Abstract][Full Text] [Related]
36. Peptidyl-arginine deiminase: an additional marker of rheumatoid arthritis. Basu PS; Majhi R; Ghosal S; Batabyal SK Clin Lab; 2011; 57(11-12):1021-5. PubMed ID: 22239037 [TBL] [Abstract][Full Text] [Related]
38. Autophagy generates citrullinated peptides in human synoviocytes: a possible trigger for anti-citrullinated peptide antibodies. Sorice M; Iannuccelli C; Manganelli V; Capozzi A; Alessandri C; Lococo E; Garofalo T; Di Franco M; Bombardieri M; Nerviani A; Misasi R; Valesini G Rheumatology (Oxford); 2016 Aug; 55(8):1374-85. PubMed ID: 27074807 [TBL] [Abstract][Full Text] [Related]
39. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients. Zhu T; Feng L Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638 [TBL] [Abstract][Full Text] [Related]
40. [New autoanti-bodies in rheumatoid arthritis: anti-citrullinated protein or peptide autoanti-bodies and the others]. Fabien N; Goetz J; Sordet C; Humbel RL; Sibilia J; Presse Med; 2008 Dec; 37(12):1756-66. PubMed ID: 18951757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]